This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Alzecure Pharma Ab. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations by Inventor Pontus Forsell
Introduction
Pontus Forsell, an innovative inventor located in Huddinge, Sweden, has made significant contributions to the field of medicinal chemistry. With a strong focus on neurotrophins and their role in various diseases, Forsell holds two notable patents that reflect his commitment to advancing healthcare solutions.
Latest Patents
Forsell's latest patents showcase his expertise in developing treatments for diseases characterized by impaired signaling of neurotrophins. One patent revolves around "Triazine derivatives for treating diseases relating to neurotrophins," which introduces a compound formula that may be beneficial in addressing conditions such as Alzheimer's disease. The second patent describes "4-substituted phenyl-1,3,5-triazine derivatives as modulators of TrK receptors," providing further insights into potential therapeutic applications for similar health issues.
Career Highlights
Currently, Pontus Forsell is associated with Alzecure Pharma AB, a company committed to developing innovative therapies for neurodegenerative diseases. His work at Alzecure Pharma emphasizes the importance of research and development in creating effective solutions that target complex medical challenges.
Collaborations
In his pursuit of innovation, Forsell collaborates with esteemed professionals like Gunnar Nordvall. These partnerships are essential for fostering creativity and enhancing the research process, ultimately leading to breakthroughs in the treatment of critical health conditions.
Conclusion
Pontus Forsell's contributions to the field of neuropharmacology through his patents highlight the ongoing advancements in medical research. His dedication to developing compounds that target neurotrophin signaling demonstrates the potential for innovative treatments to improve the lives of those affected by neurodegenerative diseases. The work of inventors like Forsell continues to inspire and drive innovation within the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile